New advice on modified-release morphine

The Royal Pharmaceutical Society has reviewed its position on brand-name prescribing of modified-release morphine preparations and fentanyl patches.

The society’s practice committee decided there was no compelling evidence to show that pain control was affected by switching between brands of modified-release morphine preparations with the same release profile. 

There was also no evidence of a difference in the rate of delivery between brands of fentanyl patches when used in accordance with the product licence, says the society. 

As a result, the practice committee does not recommend routine brand name prescribing of modified-release morphine preparations and fentanyl patches. 

The committee warned that pharmacists should aim to prevent unintentional changes of the brand supplied to patients. If the brand of strong modified-release morphine preparations needs to be changed, then the pharmacist should ensure that the patient and the patient’s carers understand and accept the need for change. 

Pharmacists were also reminded: ‘There are important differences between matrix patches and reservoir patches. Reservoir patches of fentanyl should never be cut to deliver a smaller dose because this disrupts the controlled-release mechanism.’

For general enquiries contact the society’s practice and quality improvement directorate at practice@rpsgb.org.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP dilemma: What should I do if a parent sends their child with COVID-19 symptoms to school?

GP dilemma: What should I do if a parent sends their child with COVID-19 symptoms to school?

Medical Protection's Dr Clare Devlin offers advice on how GPs should respond to parents...

GPs risk missing out on vital COVID-19 risk assessments, BMA warns

GPs risk missing out on vital COVID-19 risk assessments, BMA warns

GPs risk missing out on COVID-19 risk assessments unless practices are guaranteed...

GPs call for partial suspension of network DES amid heavy workload

GPs call for partial suspension of network DES amid heavy workload

GPs leading primary care networks (PCNs) have called for the partial suspension of...

UK COVID-19 alert level raised as GPs prioritised for testing

UK COVID-19 alert level raised as GPs prioritised for testing

The government has raised the UK's COVID-19 alert level to four amid reports that...

UK on course for 50,000 COVID-19 cases a day by mid-October

UK on course for 50,000 COVID-19 cases a day by mid-October

The UK could see 50,000 COVID-19 cases per day by mid-October, with the epidemic...

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

COVID-19 infection rates will ‘soar’ and the NHS will ‘once again be crippled’ if...